GSK (GSK.US), Inovio (INO.US), Agios (AGIO.US) queued for review, US innovative drugs face FDA approval window
智通财经2026/10/19 11:37Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Last week, the U.S. Food and Drug Administration (FDA) approved several new and expanded drug indications, with the most notable being ImmunityBio (IBRX.US)'s Anktiva approved for another type of bladder cancer. Now, all eyes are on the FDA's decisions regarding drugs for the treatment of hepatitis B, respiratory diseases, and sickle cell disease.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
